Analysis of polymorphisms in BRCA1 and BRCA2 genes in a population sample of canines from Uruguay

• Alicia Decuadro University of the Republic, Faculty of Veterinary Medicine Hospital. Montevideo, Uruguay
• Silvia Llambi University of the Republic, Faculty of Veterinary Medicine, Genetics and Animal Improvement Unit. Montevideo, Uruguay
• Alejandro Benech University of the Republic, Faculty of Veterinary Medicine Hospital. Montevideo, Uruguay
• Rosa Gagliardi University of the Republic, Faculty of Veterinary Medicine, Genetics and Animal Improvement Unit. Montevideo, Uruguay

DOI: https://doi.org/10.52973/rcfcv-e32163

Keywords: Canine BRCA1 gene, canine BRCA2 gene, mammary tumours in dogs

Abstract

In non-ovariectomized female dogs, breast tumors are the most frequent neoplasms. There are several points where canine and human breast tumors have clinical and molecular similarities. BRCA1 and BRCA2 genes have been extensively studied in both species. Regarding dogs, alterations in BRCA1 and BRCA2 have been identified in the development of breast tumors in different breeds. In this work, it was proposed to study exons 22 and 23 of the BRCA1 gene and exons 11 and 27 of the BRCA2 gene, in female dogs. It was studied two groups of female dogs, with or without mammary tumors. Regarding the genetic study of 15 loci, six were polymorphic, all of them were singles nucleotides polymorphisms (SNPs), while the other nine were monomorphic. It was obtained a low allelic variability, but at the population level, the tumor group has greater variability than the control group. On the other hand, the different analyses of possible groupings were negative, and it was not possible to clearly define groups with the parameters it was used. The foregoing may be a consequence of numerous factors such as characteristics inherent to the populations studied, such as the size of both populations; the breeds studied; tumor diversity. As it was mentioned before, the genes studied in this work have been widely related to breast cancer, both in humans and in dogs. In the former, they have been highly implicated in hereditary tumors. In dogs, it do not have that information. In the present case, it was founded no relationship between each of the markers studied and the occurrence of mammary tumor between the problem group and the control group.

References

ABDELMEGEED, S.; MOHAMMED, S. Canine mammary tumors as a model for human disease (Review). Oncol. Letter. 15: 8195-8205. 2018.

AL-DISSI, A.; HAINES, D.; SINGH, B.; KIDBEY, B. Immunohistochemical expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 in canine simple mammary gland adenocarcinomas. Canad. Vet. J. 51: 1109-1114. 2010.

BELKHIR, K.; BORSA, P.; GOUDET, J.; CHIKHI, L.; BONHOMME, F. Genetix logiciel sous Windows TM pour la génétique des populations. Laboratoire Génome, Populations, Interactions, CNRS UMR 5000. Université de Montpellier II, Montpellier, France. 2003.

CALVALCANTI, M.; CASSALI, G. Fatores prognósticos no diagnóstico clínico e histopatológico dos tumores de mama em cadelas – revisão. Rev. Clin. Vet. 11: 56–64. 2006.

CASSALI, G.; BERTAGNOLLI, A.; LAVALLE, G.; TAVARES, W.; FERREIRA, E.; CAMPOS, C. Perspectives for diagnosis, prognosis and treatment of mammary neoplasias in dogs. 34th World Small Animal Veterinary Congress – WSAVA, São Paulo, 07/21–24. Brasil. Pp 680–682. 2009.

HARTL, D.L.; CLARK, A.G. Principles of Population Genetics 3rd. Ed. Sinauer Associates. Pp 275–286. 1997.

HERMO, G.; GARCÍA, M.; TORRES, P.; GOBELLO, C. Tumores de mama en la perra. Cien. Vet. 7(1): 1–25. 2005.

KURZMAN, I.; GILBERTSON, S. Prognostic factors in canine mammary tumors. Semin. Vet. Med. Surg. 1: 25–32. 1986.

LANA, S. Tumores de glándula mamaria. In: Withrow, S.; Macewen, S. (Eds.). Oncología clínica de pequeños animales. 4ta. Ed. Multimedica. Pp. 605–620. 2008.

LIU, D.; XIONG, H.; ELLIS, A.; NORTHRUP, N.; RODRIGUEZ, C.; O´REGAN, R.; DALTON, S.; ZHAO, S. Molecular homology and difference between spontaneous canine mammary cancer and human breast cancer. Cancer Res. Sep. 74(18): 5045–5056. 2014.

MAUÉS, T.; OLIVEIRA, T.F.; EL–JAICK, K.B.; FIGUEIREDO, A.M.S.; FERREIRA, M.L.G.; FERREIRA, A.M.R. PGAM1 and TP53 mRNA levels in canine mammary carcinomas – short communication. Acta Vet. Hung. 69(1): 50–54. 2021.

NELSON, R.; COUTO, G. Alteraciones del posparto y de las mamas. In: Medicina Interna de Pequeños Animales. 4ta. Ed. Elsevier. Pp 944–974. 2010.

NIETO, A.; PEREZ-ALENZA, M.; DEL CASTILLO, N.; TABANERA, E.; CASTANO, M.; PENA, L. BRCA1 expression in canine mammary dysplasias and tumours: relationship with prognostic variables. J. Comp. Pathol. 128(4): 260–268. 2003.

OCHIAT, K.; ISHIGURO-OONUMA, T.; YOSHIKAWA, Y.; UDAGAWA, C.; KATO, Y.; WATANABE, M.; BONKOBARA, M.; MORIMATSU, M.; TOSHINORI, T. Polymorphisms of canine BRCA2 BRC repeats affecting interaction with RAD51. Biomed. Res. 36(2): 155–158. 2015.

OGILVIE, G.; MOORE, A. Neoplasia mamaria. In: Ogilvie, G.; Moore, A. (Eds.). Manejo del paciente canino oncológico. United States. Intermédica. Pp 675–687. 2008.

PAOLONI, M.; KHANNA, C. Comparative Oncology Today. Veterinary Clinics of North America: Small Anim. Pract. 37(6): 1023–1032. 2007.

RIVERA, P.; VON EULER, H. Molecular biological aspects on canine and human mammary tumors. Vet. Pathol. 48: 132-146. 2011.

RUTHANE, C.; GARRET, L. Tumores genitourinarios y de glándula mamaria. In: Ettinger, S.; Feldman, E. (Eds.). Tratado de Medicina Interna Veterinaria, enfermedades del Perro y el Gato. 6ta. Ed. Madrid. Elsevier. Volume 1. Pp 784–789. 2007.

SHORT, A.; KENNEDY, L.; BARNES, A.; FRETWELL, N.; JONES, C.; THOMSON, W.; OLLIER, W. Hardy–Weinberg Expectations in Canine Breeds: Implications for Genetic Studies. J. Heredity. 98(5): 445–451. 2007.

SOBRAL, R.; HONDA, S.; KATAYAMA, M.; BRENTANI, H.; BRENTANI, M.; PATRÃO, D.; FOLGUEIRA, M. Tumor slices as a model to evaluate doxorubicin in vitro treatment and expression of trios of genes PRSSI I, MTSS I, CLPTM I and PRSSI I, MTSS I, SMYD2 in canine mammary gland cancer. Acta Vet. Scandin. 50: 27. 2008.

SORENMO, K.; SHOFER, F.; GOLDSCHMIDT, M. Effect of spaying and timing of spaying on survival of dogs with mammary carcinoma. J. Vet. Int. Med. 14: 266–270. 2000.

THUMSER-HENNER, P.; NYTKO, K. J.; ROHRER-BLEY, C. Mutations of BRCA2 in canine mammary tumors and their targeting potential in clinical therapy. BMC Vet. Res. 16(1): 30. 2020. https://doi.org/h8gj.

VON EULER, H. Tumores de las glándulas mamarias. En: Dobson, J.; Lascelles, B. (Eds.). Manual de Oncología de Pequeños Animales. 3ra. Ed. Lexus. Pp. 351–365. 2014.

YOSHIKAWA, Y.; MORIMATSU, M.; OCHIAI, K.; OKUDA, K.; TAODA, T.; CHIKAZAWA, S.; SHIMAMURA, A.; OMI, T. Establishment of a PCR analysis method for canine BRCA2. BMC. Res. Notes. 5: 173. 2012.